- The German drug wholesale, chemicals and dietary products group, Altana AG, has said sales and profits in 1995 will be sustained at 1994 levels. Group sales for the first half of 1995 rose 3% to 1.5 billion Deutschemarks ($1.0 billion). The pharmaceutical division, represented by Byk Gulden, achieved sales for the half-year that were up 5% to 727 million marks.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze